|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2001 to 2100 out of 3295 for Kras

<< First    < Previous  |  Next >    Last >>
0.016s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
37344586 | J:340082
First Author: Gallini S
Year: 2023
Journal: Nature
Title: Injury prevents Ras mutant cell expansion in mosaic skin.
Volume: 619
Issue: 7968
Pages: 167-175
•
•
•
•
•
Publication
21474066 | J:310528
First Author: Kennedy AL
Year: 2011
Journal: Mol Cell
Title: Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.
Volume: 42
Issue: 1
Pages: 36-49
•
•
•
•
•
Publication
31578522 | J:283349
First Author: Aykut B
Year: 2019
Journal: Nature
Title: The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.
Volume: 574
Issue: 7777
Pages: 264-267
•
•
•
•
•
Publication
24346431 | J:208362
First Author: Aguilera KY
Year: 2014
Journal: Cancer Res
Title: Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 4
Pages: 1032-44
•
•
•
•
•
Publication
33328637 | J:303984
First Author: Pastushenko I
Year: 2021
Journal: Nature
Title: Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
Volume: 589
Issue: 7842
Pages: 448-455
•
•
•
•
•
Publication
23188079 | J:193125
First Author: Lapouge G
Year: 2012
Journal: EMBO J
Title: Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness.
Volume: 31
Issue: 24
Pages: 4563-75
•
•
•
•
•
Publication
25575080 | J:224028
First Author: Beck B
Year: 2015
Journal: Cell Stem Cell
Title: Different levels of Twist1 regulate skin tumor initiation, stemness, and progression.
Volume: 16
Issue: 1
Pages: 67-79
•
•
•
•
•
Publication
35418690 | J:324774
First Author: Kidger AM
Year: 2022
Journal: Oncogene
Title: Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6.
Volume: 41
Issue: 20
Pages: 2811-2823
•
•
•
•
•
Publication
37267954 | J:337912
First Author: Prieto LI
Year: 2023
Journal: Cancer Cell
Title: Senescent alveolar macrophages promote early-stage lung tumorigenesis.
Volume: 41
Issue: 7
Pages: 1261-1275.e6
•
•
•
•
•
Publication
19079133 | J:143043
First Author: Zhao B
Year: 2009
Journal: EMBO Rep
Title: Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice.
Volume: 10
Issue: 1
Pages: 71-8
•
•
•
•
•
Publication
27376576 | J:240139
First Author: Jiang H
Year: 2016
Journal: Nat Med
Title: Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Volume: 22
Issue: 8
Pages: 851-60
•
•
•
•
•
Publication
26537451 | J:228038
 
First Author: Robles-Oteiza C
Year: 2015
Journal: Nat Commun
Title: Recombinase-based conditional and reversible gene regulation via XTR alleles.
Volume: 6
Pages: 8783
•
•
•
•
•
Publication
37887282 | J:341955
 
First Author: Lee JY
Year: 2023
Journal: Cells
Title: Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.
Volume: 12
Issue: 20
•
•
•
•
•
Publication
36351380 | J:331105
First Author: Millar FR
Year: 2022
Journal: Cell Rep
Title: Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer.
Volume: 41
Issue: 6
Pages: 111596
•
•
•
•
•
Publication
26738797 | J:234124
First Author: Whitley MJ
Year: 2016
Journal: Sci Transl Med
Title: A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.
Volume: 8
Issue: 320
Pages: 320ra4
•
•
•
•
•
Publication
35271824 | J:333404
First Author: Somani VK
Year: 2022
Journal: Gastroenterology
Title: IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Volume: 162
Issue: 7
Pages: 2047-2062
•
•
•
•
•
Publication
34381046 | J:308946
First Author: Tan X
Year: 2021
Journal: Nat Commun
Title: Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation.
Volume: 12
Issue: 1
Pages: 4853
•
•
•
•
•
Publication
31983610 | J:285699
First Author: Cheung EC
Year: 2020
Journal: Cancer Cell
Title: Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer.
Volume: 37
Issue: 2
Pages: 168-182.e4
•
•
•
•
•
Publication
24740995 | J:217850
First Author: Caswell DR
Year: 2014
Journal: Cancer Discov
Title: Obligate progression precedes lung adenocarcinoma dissemination.
Volume: 4
Issue: 7
Pages: 781-9
•
•
•
•
•
Publication
28363999 | J:242304
First Author: Schmitt A
Year: 2017
Journal: Cancer Res
Title: ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma.
Volume: 77
Issue: 11
Pages: 3040-3056
•
•
•
•
•
Publication
39039076 | J:360604
First Author: Assouline B
Year: 2024
Journal: Nat Commun
Title: Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice.
Volume: 15
Issue: 1
Pages: 6162
•
•
•
•
•
Publication
34534464 | J:310998
First Author: Burger ML
Year: 2021
Journal: Cell
Title: Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors.
Volume: 184
Issue: 19
Pages: 4996-5014.e26
•
•
•
•
•
Publication
36621763 | J:333476
 
First Author: Taylor AJ
Year: 2023
Journal: Mol Metab
Title: Islet amyloid polypeptide does not suppress pancreatic cancer.
Volume: 68
Pages: 101667
•
•
•
•
•
Publication
19903759 | J:154907
First Author: Kumar MS
Year: 2009
Journal: Genes Dev
Title: Dicer1 functions as a haploinsufficient tumor suppressor.
Volume: 23
Issue: 23
Pages: 2700-4
•
•
•
•
•
Publication
26234681 | J:234210
First Author: Dodd RD
Year: 2016
Journal: Oncogene
Title: Myogenic transcription factors regulate pro-metastatic miR-182.
Volume: 35
Issue: 14
Pages: 1868-75
•
•
•
•
•
Publication
35013174 | J:317790
First Author: Cheung PF
Year: 2022
Journal: Nat Commun
Title: Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Volume: 13
Issue: 1
Pages: 156
•
•
•
•
•
Publication
35017504 | J:317792
First Author: Patel RS
Year: 2022
Journal: Nat Commun
Title: A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells.
Volume: 13
Issue: 1
Pages: 256
•
•
•
•
•
Publication
35228570 | J:321839
First Author: Murray CW
Year: 2022
Journal: Nat Commun
Title: LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer.
Volume: 13
Issue: 1
Pages: 1090
•
•
•
•
•
Publication
39515330 | J:358842
     
First Author: Tang Z
Year: 2024
Journal: Dev Cell
Title: A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression.
•
•
•
•
•
Publication
37889752 | J:342861
First Author: Zavitsanou AM
Year: 2023
Journal: Cell Rep
Title: KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.
Volume: 42
Issue: 11
Pages: 113295
•
•
•
•
•
Publication
31107239 | J:277350
   
First Author: Kang YP
Year: 2019
Journal: Elife
Title: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Volume: 8
•
•
•
•
•
Publication
30224540 | J:269993
First Author: Schug C
Year: 2019
Journal: Mol Cancer Res
Title: A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.
Volume: 17
Issue: 1
Pages: 310-320
•
•
•
•
•
Publication
39037766 | J:353863
First Author: Bermejo-Rodriguez C
Year: 2024
Journal: Cancer Res
Title: Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
Volume: 84
Issue: 18
Pages: 2968-2984
•
•
•
•
•
Publication
24458094 | J:288211
First Author: Zhang W
Year: 2014
Journal: Cell Res
Title: VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
Volume: 24
Issue: 3
Pages: 331-43
•
•
•
•
•
Publication
28754670 | J:245578
First Author: Liu Y
Year: 2017
Journal: Cancer Res
Title: Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma.
Volume: 77
Issue: 18
Pages: 5068-5076
•
•
•
•
•
Publication
30305738 | J:266541
First Author: Song M
Year: 2018
Journal: Nature
Title: IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.
Volume: 562
Issue: 7727
Pages: 423-428
•
•
•
•
•
Publication
31534224 | J:280631
First Author: Morris JP 4th
Year: 2019
Journal: Nature
Title: α-Ketoglutarate links p53 to cell fate during tumour suppression.
Volume: 573
Issue: 7775
Pages: 595-599
•
•
•
•
•
Publication
26988419 | J:232399
First Author: Reynoird N
Year: 2016
Journal: Genes Dev
Title: Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
Volume: 30
Issue: 7
Pages: 772-85
•
•
•
•
•
Publication
30323292 | J:317894
First Author: Messenger ZJ
Year: 2018
Journal: Cell Death Dis
Title: C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Volume: 9
Issue: 11
Pages: 1054
•
•
•
•
•
Publication
33127675 | J:313903
 
First Author: Rossi Sebastiano M
Year: 2020
Journal: Sci Adv
Title: ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression.
Volume: 6
Issue: 44
•
•
•
•
•
Publication
31043430 | J:274251
First Author: Fujimoto TN
Year: 2019
Journal: Cancer Res
Title: Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.
Volume: 79
Issue: 9
Pages: 2327-2338
•
•
•
•
•
Publication
37712427 | J:340296
 
First Author: Masuda T
Year: 2023
Journal: J Clin Invest
Title: Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis.
Volume: 133
Issue: 18
•
•
•
•
•
Publication
27543868 | J:309224
First Author: Sugiyama Y
Year: 2016
Journal: Pol J Pathol
Title: Gli2 protein expression level is a feasible marker of ligand-dependent hedgehog activation in pancreatic neoplasms.
Volume: 67
Issue: 2
Pages: 136-44
•
•
•
•
•
Publication
30996350 | J:280283
First Author: Shi Y
Year: 2019
Journal: Nature
Title: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
Volume: 569
Issue: 7754
Pages: 131-135
•
•
•
•
•
Publication
36175792 | J:333728
First Author: Rahrmann EP
Year: 2022
Journal: Nat Genet
Title: The NALCN channel regulates metastasis and nonmalignant cell dissemination.
Volume: 54
Issue: 12
Pages: 1827-1838
•
•
•
•
•
Publication
22396451 | J:183892
First Author: Mullany LK
Year: 2012
Journal: Endocrinology
Title: Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.
Volume: 153
Issue: 4
Pages: 1638-48
•
•
•
•
•
Publication
35139353 | J:336911
First Author: Hezaveh K
Year: 2022
Journal: Immunity
Title: Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
Volume: 55
Issue: 2
Pages: 324-340.e8
•
•
•
•
•
Publication
28031255 | J:240629
First Author: Rath N
Year: 2017
Journal: EMBO Mol Med
Title: ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth.
Volume: 9
Issue: 2
Pages: 198-218
•
•
•
•
•
Publication
32243837 | J:287288
First Author: Alam H
Year: 2020
Journal: Cancer Cell
Title: KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Volume: 37
Issue: 4
Pages: 599-617.e7
•
•
•
•
•
Publication
29191879 | J:274076
 
First Author: Engblom C
Year: 2017
Journal: Science
Title: Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.
Volume: 358
Issue: 6367
•
•
•
•
•
Publication
39690148 | J:359776
First Author: Greenwood HE
Year: 2024
Journal: Nat Commun
Title: Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography.
Volume: 15
Issue: 1
Pages: 10484
•
•
•
•
•
Publication
24465581 | J:212340
First Author: Choi SH
Year: 2014
Journal: PLoS One
Title: MMP9 processing of HSPB1 regulates tumor progression.
Volume: 9
Issue: 1
Pages: e85509
•
•
•
•
•
Publication
24477002 | J:212506
First Author: Sayin VI
Year: 2014
Journal: Sci Transl Med
Title: Antioxidants accelerate lung cancer progression in mice.
Volume: 6
Issue: 221
Pages: 221ra15
•
•
•
•
•
Publication
23906982 | J:204376
First Author: Eisinger-Mathason TS
Year: 2013
Journal: Cancer Discov
Title: Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
Volume: 3
Issue: 10
Pages: 1190-205
•
•
•
•
•
Publication
35696550 | J:327832
First Author: Makino Y
Year: 2022
Journal: Cancer Res
Title: Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis.
Volume: 82
Issue: 16
Pages: 2860-2873
•
•
•
•
•
Publication
30228296 | J:283080
First Author: Chiou SH
Year: 2018
Journal: Sci Rep
Title: Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.
Volume: 8
Issue: 1
Pages: 14008
•
•
•
•
•
Publication
27514406 | J:236871
First Author: Jokić M
Year: 2016
Journal: Mol Cancer Res
Title: Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.
Volume: 14
Issue: 11
Pages: 1110-1123
•
•
•
•
•
Publication
27506299 | J:310029
First Author: Grünwald B
Year: 2016
Journal: Gastroenterology
Title: Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Volume: 151
Issue: 5
Pages: 1011-1024.e7
•
•
•
•
•
Publication
27889319 | J:253964
First Author: Latil M
Year: 2017
Journal: Cell Stem Cell
Title: Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition.
Volume: 20
Issue: 2
Pages: 191-204.e5
•
•
•
•
•
Publication
34135508 | J:326203
First Author: Casanova-Acebes M
Year: 2021
Journal: Nature
Title: Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.
Volume: 595
Issue: 7868
Pages: 578-584
•
•
•
•
•
Publication
31665640 | J:285273
First Author: Bott AJ
Year: 2019
Journal: Cell Rep
Title: Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism.
Volume: 29
Issue: 5
Pages: 1287-1298.e6
•
•
•
•
•
Publication
33357435 | J:301685
First Author: Leung C
Year: 2020
Journal: Cell Rep
Title: Lgr5 Marks Adult Progenitor Cells Contributing to Skeletal Muscle Regeneration and Sarcoma Formation.
Volume: 33
Issue: 12
Pages: 108535
•
•
•
•
•
Publication
27160068 | J:235005
First Author: Lowry WE
Year: 2016
Journal: J Invest Dermatol
Title: Exploiting Mouse Models to Study Ras-Induced Cutaneous Squamous Cell Carcinoma.
Volume: 136
Issue: 8
Pages: 1543-8
•
•
•
•
•
Publication
32535617 | J:293693
First Author: Hyslop SR
Year: 2020
Journal: Oncogene
Title: Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma.
Volume: 39
Issue: 29
Pages: 5177-5186
•
•
•
•
•
Publication
39577420 | J:360628
First Author: Hänggi K
Year: 2024
Journal: Cancer Cell
Title: Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity.
Volume: 42
Issue: 12
Pages: 2015-2031.e11
•
•
•
•
•
Publication
25977335 | J:222933
First Author: Razidlo GL
Year: 2015
Journal: Cancer Res
Title: Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Volume: 75
Issue: 14
Pages: 2907-15
•
•
•
•
•
Publication
22084065 | J:180399
First Author: Olson P
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.
Volume: 108
Issue: 49
Pages: E1275-84
•
•
•
•
•
Publication
21502519 | J:172216
First Author: White AC
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Defining the origins of Ras/p53-mediated squamous cell carcinoma.
Volume: 108
Issue: 18
Pages: 7425-30
•
•
•
•
•
Publication
28530655 | J:254091
First Author: Rogers ZN
Year: 2017
Journal: Nat Methods
Title: A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
Volume: 14
Issue: 7
Pages: 737-742
•
•
•
•
•
Publication
20956321 | J:166159
First Author: Gao Y
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.
Volume: 107
Issue: 44
Pages: 18892-7
•
•
•
•
•
Publication
19878870 | J:153948
First Author: Gidekel Friedlander SY
Year: 2009
Journal: Cancer Cell
Title: Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.
Volume: 16
Issue: 5
Pages: 379-89
•
•
•
•
•
Publication
38272889 | J:352424
First Author: He B
Year: 2024
Journal: Cell Death Dis
Title: Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state.
Volume: 15
Issue: 1
Pages: 89
•
•
•
•
•
Publication
25985394 | J:309322
First Author: Costa-Silva B
Year: 2015
Journal: Nat Cell Biol
Title: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Volume: 17
Issue: 6
Pages: 816-26
•
•
•
•
•
Publication
26744531 | J:231333
First Author: Choi SH
Year: 2016
Journal: Cancer Res
Title: HSPB1 Inhibits the Endothelial-to-Mesenchymal Transition to Suppress Pulmonary Fibrosis and Lung Tumorigenesis.
Volume: 76
Issue: 5
Pages: 1019-30
•
•
•
•
•
Publication
30809277 | J:349142
First Author: Kuo TL
Year: 2019
Journal: Theranostics
Title: β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer.
Volume: 9
Issue: 2
Pages: 324-336
•
•
•
•
•
Publication
29596465 | J:261064
First Author: Germino EA
Year: 2018
Journal: PLoS One
Title: Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.
Volume: 13
Issue: 3
Pages: e0194998
•
•
•
•
•
Publication
28228261 | J:254389
First Author: Cicchini M
Year: 2017
Journal: Cell Rep
Title: Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.
Volume: 18
Issue: 8
Pages: 1958-1969
•
•
•
•
•
Publication
25519892 | J:223245
 
First Author: Herter-Sprie GS
Year: 2014
Journal: Nat Commun
Title: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models.
Volume: 5
Pages: 5870
•
•
•
•
•
Publication
24445999 | J:225254
 
First Author: Rao S
Year: 2014
Journal: Nat Commun
Title: A dual role for autophagy in a murine model of lung cancer.
Volume: 5
Pages: 3056
•
•
•
•
•
Publication
32034305 | J:297949
First Author: Saliakoura M
Year: 2020
Journal: Oncogene
Title: The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.
Volume: 39
Issue: 14
Pages: 2948-2960
•
•
•
•
•
Publication
29241546 | J:254404
First Author: Faget J
Year: 2017
Journal: Cell Rep
Title: Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.
Volume: 21
Issue: 11
Pages: 3190-3204
•
•
•
•
•
Publication
38460517 | J:346858
First Author: Ku B
Year: 2024
Journal: Cell Rep Med
Title: PRMT1 promotes pancreatic cancer development and resistance to chemotherapy.
Volume: 5
Issue: 3
Pages: 101461
•
•
•
•
•
Publication
34358448 | J:311809
First Author: Freed-Pastor WA
Year: 2021
Journal: Cancer Cell
Title: The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer.
Volume: 39
Issue: 10
Pages: 1342-1360.e14
•
•
•
•
•
Publication
31973890 | J:286259
First Author: Olivero CE
Year: 2020
Journal: Mol Cell
Title: p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
Volume: 77
Issue: 4
Pages: 761-774.e8
•
•
•
•
•
Publication
37695905 | J:346096
First Author: Yousefi M
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma.
Volume: 120
Issue: 38
Pages: e2303224120
•
•
•
•
•
Publication
33854047 | J:306084
First Author: Caronni N
Year: 2021
Journal: Nat Commun
Title: TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses.
Volume: 12
Issue: 1
Pages: 2237
•
•
•
•
•
Publication
32196080 | J:289864
 
First Author: Ward NP
Year: 2020
Journal: J Exp Med
Title: Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function.
Volume: 217
Issue: 6
•
•
•
•
•
Publication
35082384 | J:322734
First Author: Steiner S
Year: 2022
Journal: Oncogene
Title: De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer.
Volume: 41
Issue: 10
Pages: 1507-1517
•
•
•
•
•
Publication
22787119 | J:191017
First Author: Hezel AF
Year: 2012
Journal: Cancer Res
Title: TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.
Volume: 72
Issue: 18
Pages: 4840-5
•
•
•
•
•
Publication
33288885 | J:302327
First Author: Lu J
Year: 2021
Journal: Oncogene
Title: Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Volume: 40
Issue: 5
Pages: 922-936
•
•
•
•
•
Publication
32434991 | J:306794
 
First Author: Hidalgo-Sastre A
Year: 2020
Journal: JCI Insight
Title: Loss of Wasl improves pancreatic cancer outcome.
Volume: 5
Issue: 10
•
•
•
•
•
Publication
32025000 | J:291017
First Author: Sethi NS
Year: 2020
Journal: Nat Genet
Title: Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.
Volume: 52
Issue: 2
Pages: 219-230
•
•
•
•
•
Publication
30002193 | J:266844
First Author: Caswell DR
Year: 2018
Journal: Mol Cancer Res
Title: Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Volume: 16
Issue: 11
Pages: 1737-1749
•
•
•
•
•
Publication
37922313 | J:343573
First Author: Salahudeen AA
Year: 2023
Journal: Cell Rep
Title: Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis.
Volume: 42
Issue: 11
Pages: 113355
•
•
•
•
•
Publication
30198904 | J:266941
First Author: Hsu J
Year: 2018
Journal: J Clin Invest
Title: Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Volume: 128
Issue: 10
Pages: 4654-4668
•
•
•
•
•
Publication
35705813 | J:330295
First Author: Jaeger AM
Year: 2022
Journal: Nature
Title: Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Volume: 607
Issue: 7917
Pages: 149-155
•
•
•
•
•
Publication
26341400 | J:233648
First Author: Joshi NS
Year: 2015
Journal: Immunity
Title: Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.
Volume: 43
Issue: 3
Pages: 579-90
•
•
•
•
•
Publication
23540692 | J:197249
First Author: Li L
Year: 2013
Journal: Cell
Title: Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion.
Volume: 153
Issue: 1
Pages: 86-100
•
•
•
•
•
Publication
33984270 | J:308557
First Author: Ravi A
Year: 2021
Journal: Dev Cell
Title: PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay.
Volume: 56
Issue: 11
Pages: 1661-1676.e10
•
•
•
•
•
Publication
31267692 | J:290544
First Author: Uribesalgo I
Year: 2019
Journal: EMBO Mol Med
Title: Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Volume: 11
Issue: 8
Pages: e9266
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom